Popular Articles

Lupus Drug Benlysta Effective In Phase 3 Trials
In what has been described as the first lupus drug in decades to show effectiveness in phase 3 clinical trials, the announcement that Benlysta
generic viagra online
WHO Approves Second HPV Vaccine
The WHO announced Thursday it had approved a second cervical cancer vaccine, opening "U.N. agencies and partners [to] now officially buy millions of doses of the vaccine for poor countries worldwide," where an estimated 80 percent of the 280,000 annual deaths from cervical cancer occur each year, the AP/Google.com reports (7/9).
News of the day
Blogs Comment On Supreme Court Decisions, Obama Administration, Other Topics
The following summarizes selected women"s health-related blog entries. ~ "Just Released: Gains and Losses for Women in 2008-09 Supreme Court Decisions," National Women"s Law Center"s "Womenstake": The Supreme Court"s 2008-2009 term, which concluded Monday, included "several crucial decisions that demonstrate the impact of the court on women"s lives," according to the blog post, which summarizes a new analysis from NWLC on the cases. For example, the blog post says that the rulings in Fitzgerald v. Barnstable School Committee and Crawford v. Metropolitan Government of Nashville and Davidson County, Tenn., increased employees" protections against discrimination in the workplace. However, the rulings in Ricci v. DeStetano -- which overturned an appellate court"s anti-discrimination ruling -- and AT&T Corp. v. Hulteen -- which "permitted AT&T to pay women lower pension benefits for the rest of their lives" -- were "not as positive," the blog entry says. NWLC Co-President Marcia Greenberger said that the Supreme Court "ignored the realities of the workplace and the intent of Congress and ruled against female workers" in AT&T v. Hulteen. Greenberger also said that such cases "underscore why every seat on the Supreme Court is of paramount importance to women," adding that it is "absolutely critical" that Supreme Court nominees have "a strong commitment to upholding and enforcing women"s basic legal rights and protections" ("Womenstake," National Women"s Law Center, 6/29).~ "Waldman and Saletan: Oh What a Fine Bromance!" Jodi Jacobson, RH Reality Check: In a recent bloggingheads.tv chat on "common ground" in the abortion-rights debate, Slate columnist Will Saletan and Beliefnet Editor-in-Chief Steve Waldman "spent as much time as possible complimenting each other"s work" and "as little as possible on any real substance regarding reproductive health and choice issues," Jacobson writes. It is "clear that the Obama administration"s stated intention to create "a common ground platform"" on abortion rights has become "a full employment program for both Waldman and Saletan," she writes. Jacobson continues, "So perhaps the most striking thing about the conversation was that, in the end, they both effectively concluded that the common ground enterprise was a "just for show" political strategy," and that the "real strategies" necessary to reduce the need for abortion "are the very prevention programs least likely to be supported by the far right. (Revelation!)." She adds, "However, they came to this conclusion through the same faux-expert uninformed arguments that characterize their columns." During the "Will-interviews-Steve format," Saletan "revealed once again that there is no core philosophy or framework underlying his ever-shifting positions on choice and abortion," according to Jacobson. She adds that "Waldman, for his part, several times underscored what is clear from reading his work": that he "just throws things "out there" without considered thought" about what "might be good versus bad data, not understanding how to read evidence," and "oblivious or uncaring about the effects his free-form moralistic misinformation and opinions might actually have on an already polarized debate." According to Jacobson, "Public policies affecting sexual and reproductive health issues" should be "based first and foremost on public health and on promoting individual rights balanced by individual responsibilities," but "as anyone living on Planet Earth knows, sex and reproduction have become the front in a war waged by ultra-conservative religious and political forces for which Waldman serves as a paid flacky." She continues, "In fact, Waldman himself stated during the program: "I have a corporate interest in injecting religion into every debate."" Jacobson states, "Reading and watching this duo is like buying the OK! magazine version of the culture wars at the grocery store; they put whatever sells on the front cover, no matter the truth or consequences.
Endocrinology

BioTech Medics Announces SHBAN Antiviral Solution Undergoing H1N1 (Swine) Influenza Efficacy Testing

BioTech Medics, Inc. (PINKSHEETS: BMCS) announces that it has contracted to start conducting independent clinical testing of its patented SHBAN™ Antiviral Hand Sanitizer Solution to prove it kills the H1N1 (Swine) Influenza A virus in compliance with FDA and EPA standards. In 2007 BioTech conducted an independent study to determine the efficacy of virucidal SHBAN against Avian H5N1 Influenza NIBRG-14 Virus (also known as the Avian Bird Flu). BioTech reported that the SHBAN Solution had clinically proven its anti-viral properties and had topically killed the Avian Influenza virus. Significantly, SHBAN was proven non-toxic with "no cytotoxicity observed on the MDCK cell line after treatment." SHBAN is a bio-degradable product superior to most anti-viral and anti-bacterial disinfectants because 1) SHBAN is longer lasting, SHBAN does not evaporate within 15 seconds after application and cease working (like alcohol gels); 2) SHBAN is non-toxic when used as directed on humans and animals; 3) SHBAN is non-staining, non-bleaching; 4) SHBAN is non-flammable and 5) SHBAN has no harmful or toxic odors. Most hand sanitizer products cannot make all of these claims. BioTech currently sells a 3 oz SHBAN™ Go Anywhere Hand Atomizer Spray Bottle that complies with TSA carry-on travel regulations. SHBAN sales are up significantly in 2009. BioTech is releasing this Fall 1 oz and 16 oz bottles together with SHBAN Hand Wipe Towelettes. The World Health Organization (WHO) has declared the H1N1 Influenza a worldwide pandemic 6, so it is essential that people buying hand sanitizers know that SHBAN can prove that SHBAN kills the H1N1 Influenza Virus on the hands. SHBAN is protected under US Letters of Patent #5,514,808, #5,574,050, #5,679,711 and #5,585,391 and pending international patents. SHBAN is a trademark of BioTech Medics, Inc. BioTech is seeking and negotiating USA and foreign distributorships at this time. SHBAN™ in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against Staph. Aureus, Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. BioTech Medics, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):